Dr. Binod Dhakal, MD

NPI: 1710218011
Total Payments
$605,281
2024 Payments
$264,973
Companies
28
Transactions
445
Medicare Patients
1,078
Medicare Billing
$364,665

Payment Breakdown by Category

Other$227,404 (37.6%)
Consulting$187,188 (30.9%)
Research$145,859 (24.1%)
Travel$33,826 (5.6%)
Food & Beverage$10,993 (1.8%)
Education$12.45 (0.0%)

Payments by Nature

Nature of Payment Amount Transactions Share
Consulting Fee $187,188 84 30.9%
Compensation for services other than consulting, including serving as faculty or as a speaker at a venue other than a continuing education program $159,729 62 26.4%
Unspecified $145,859 66 24.1%
Honoraria $67,675 18 11.2%
Travel and Lodging $33,826 72 5.6%
Food and Beverage $10,993 142 1.8%
Education $12.45 1 0.0%

Payments by Type

General
$459,422
379 transactions
Research
$145,859
66 transactions

Top Paying Companies

Company Total Records Latest Year
IGI Inc $130,671 58 $0 (2024)
Karyopharm Therapeutics Inc. $85,718 43 $0 (2024)
Janssen Biotech, Inc. $74,838 64 $0 (2024)
Celgene Corporation $62,287 75 $0 (2024)
PFIZER INC. $46,554 32 $0 (2024)
GENZYME CORPORATION $31,753 25 $0 (2024)
E.R. Squibb & Sons, L.L.C. $21,580 12 $0 (2024)
Legend Biotech USA Inc. $21,207 19 $0 (2024)
ABBVIE INC. $18,225 3 $0 (2024)
Ichnos Sciences Inc. $15,188 8 $0 (2023)

Payment History by Year

Year Amount Transactions Top Company
2024 $264,973 168 IGI Inc ($130,671)
2023 $113,391 87 Janssen Biotech, Inc. ($26,393)
2022 $81,687 55 Janssen Biotech, Inc. ($28,515)
2021 $60,431 35 Karyopharm Therapeutics Inc. ($25,458)
2020 $17,469 14 Celgene Corporation ($9,802)
2019 $26,580 42 Celgene Corporation ($22,900)
2018 $33,863 37 Celgene Corporation ($25,331)
2017 $6,888 7 Millennium Pharmaceuticals, Inc. ($6,715)

All Payment Transactions

445 individual payment records from CMS Open Payments — Page 1 of 18

Date Company Product Nature Form Amount Type
12/20/2024 IGI Inc Cash or cash equivalent $2,310.00 Research
Study: ISB 1442-101
12/20/2024 IGI Inc Cash or cash equivalent $2,310.00 Research
Study: ISB 1442-101
12/20/2024 IGI Inc Cash or cash equivalent $1,875.00 Research
Study: ISB 1442-101
12/20/2024 IGI Inc Cash or cash equivalent $1,700.00 Research
Study: ISB 1442-101
12/20/2024 IGI Inc Cash or cash equivalent $1,580.00 Research
Study: ISB 1442-101
12/20/2024 IGI Inc Cash or cash equivalent $750.00 Research
Study: ISB 1442-101
12/20/2024 IGI Inc Cash or cash equivalent $700.00 Research
Study: ISB 1442-101
12/20/2024 IGI Inc Cash or cash equivalent $690.00 Research
Study: ISB 1442-101
12/20/2024 IGI Inc Cash or cash equivalent $690.00 Research
Study: ISB 1442-101
12/20/2024 IGI Inc Cash or cash equivalent $330.00 Research
Study: ISB 1442-101
12/20/2024 IGI Inc Cash or cash equivalent $330.00 Research
Study: ISB 1442-101
12/20/2024 IGI Inc Cash or cash equivalent $330.00 Research
Study: ISB 1442-101
12/20/2024 IGI Inc Cash or cash equivalent $330.00 Research
Study: ISB 1442-101
12/20/2024 IGI Inc Cash or cash equivalent $330.00 Research
Study: ISB 1442-101
12/20/2024 IGI Inc Cash or cash equivalent $330.00 Research
Study: ISB 1442-101
12/20/2024 IGI Inc Cash or cash equivalent $312.50 Research
Study: ISB 1442-101
12/20/2024 IGI Inc Cash or cash equivalent $312.50 Research
Study: ISB 1442-101
12/20/2024 IGI Inc Cash or cash equivalent $312.50 Research
Study: ISB 1442-101
12/20/2024 IGI Inc Cash or cash equivalent $312.50 Research
Study: ISB 1442-101
12/20/2024 IGI Inc Cash or cash equivalent $312.50 Research
Study: ISB 1442-101
12/20/2024 IGI Inc Cash or cash equivalent $312.50 Research
Study: ISB 1442-101
12/16/2024 ModernaTX, Inc. Food and Beverage In-kind items and services $67.02 General
12/10/2024 PFIZER INC. ELREXFIO (Drug) Compensation for services other than consulting, including serving as faculty or as a speaker at a venue other than a continuing education program Cash or cash equivalent $1,260.00 General
Category: ONCOLOGY
12/09/2024 Janssen Biotech, Inc. DARZALEX (Biological) Food and Beverage In-kind items and services $59.30 General
Category: Oncology
12/09/2024 BeiGene USA, Inc. Food and Beverage In-kind items and services $40.20 General

Research Studies & Clinical Trials

Study Name Company Amount Records
ISB 1442-101 IGI Inc $130,671 58
ISB 1442 Ichnos Sciences Inc. $15,188 8

Medicare Billing by Year

Year Procedures Beneficiaries Services Submitted Medicare Paid
2023 6 306 1,229 $477,750 $89,722
2022 5 297 1,133 $444,876 $93,469
2021 6 266 1,089 $451,196 $108,638
2020 6 209 772 $310,675 $72,836
Total Patients
1,078
Total Services
4,223
Medicare Billing
$364,665
Procedure Codes
23

All Medicare Procedures & Services

23 procedure records from CMS Medicare Utilization

HCPCS Description Setting Year Patients Services Charges Medicare Paid Ratio
99214 Established patient office or other outpatient visit, 30-39 minutes Facility 2023 174 893 $316,935 $60,363 19.0%
99233 Subsequent hospital care with moderate levelof medical decision making, if using time, at least 50 minutes Facility 2023 35 132 $64,416 $11,819 18.3%
99215 Established patient office or other outpatient visit, 40-54 minutes Facility 2023 41 72 $39,800 $7,571 19.0%
99232 Subsequent hospital care with moderate levelof medical decision making, if using time, at least 35 minutes Facility 2023 29 103 $34,505 $6,130 17.8%
99223 Initial hospital care with moderate level of medical decision making, if using time, at least 75 minutes Facility 2023 14 16 $12,448 $2,082 16.7%
99205 New patient office or other outpatient visit, 60-74 minutes Facility 2023 13 13 $9,646 $1,759 18.2%
99214 Established patient office or other outpatient visit, 30-39 minutes Facility 2022 167 803 $277,035 $56,563 20.4%
G9678 Oncology care model (ocm) monthly enhanced oncology services (meos) payment for ocm enhanced services. g9678 payments may only be made to ocm practitioners for ocm beneficiaries for the furnishment of enhanced services as defined in the ocm participation a Facility 2022 25 84 $39,480 $13,410 34.0%
99233 Follow-up hospital inpatient care per day, typically 35 minutes Facility 2022 27 132 $62,568 $10,275 16.4%
99215 Established patient office or other outpatient visit, 40-54 minutes Facility 2022 53 89 $47,793 $10,051 21.0%
99205 New patient office or other outpatient visit, 60-74 minutes Facility 2022 25 25 $18,000 $3,170 17.6%
G9678 Oncology care model (ocm) monthly enhanced oncology services (meos) payment for ocm enhanced services. g9678 payments may only be made to ocm practitioners for ocm beneficiaries for the furnishment of enhanced services as defined in the ocm participation a Facility 2021 38 254 $115,824 $40,827 35.2%
99214 Established patient outpatient visit, total time 30-39 minutes Facility 2021 117 514 $172,190 $37,293 21.7%
99215 Established patient outpatient visit, total time 40-54 minutes Facility 2021 47 135 $70,335 $14,776 21.0%
99233 Subsequent hospital inpatient care, typically 35 minutes per day Facility 2021 31 153 $70,380 $12,064 17.1%
99205 New patient outpatient visit, total time 60-74 minutes Facility 2021 21 21 $14,679 $2,703 18.4%
99239 Hospital discharge day management, more than 30 minutes Facility 2021 12 12 $7,788 $976.68 12.5%
G9678 Oncology care model (ocm) monthly enhanced oncology services (meos) payment for ocm enhanced services. g9678 payments may only be made to ocm practitioners for ocm beneficiaries for the furnishment of enhanced services as defined in the ocm participation a Facility 2020 34 220 $97,460 $35,043 36.0%
99214 Established patient office or other outpatient, visit typically 25 minutes Facility 2020 79 300 $97,500 $17,363 17.8%
99233 Subsequent hospital inpatient care, typically 35 minutes per day Facility 2020 25 125 $55,875 $10,172 18.2%
99215 Established patient office or other outpatient, visit typically 40 minutes Facility 2020 41 97 $49,082 $7,991 16.3%
99205 New patient office or other outpatient visit, typically 60 minutes Facility 2020 12 12 $8,148 $1,285 15.8%
99443 Physician telephone patient service, 21-30 minutes of medical discussion Facility 2020 18 18 $2,610 $982.04 37.6%

About Dr. Binod Dhakal, MD

Dr. Binod Dhakal, MD is a Internal Medicine healthcare provider based in Milwaukee, Wisconsin. This provider has been registered with the National Plan and Provider Enumeration System (NPPES) since 01/26/2010. The National Provider Identifier (NPI) number assigned to this provider is 1710218011.

According to the Centers for Medicare & Medicaid Services (CMS) Open Payments database, Dr. Binod Dhakal, MD has received a total of $605,281 in payments from pharmaceutical and medical device companies, with $264,973 received in 2024. These payments were reported across 445 transactions from 28 companies. The most common payment nature is "Consulting Fee" ($187,188).

As a Medicare-enrolled provider, Dhakal has provided services to 1,078 Medicare beneficiaries, totaling 4,223 services with total Medicare billing of $364,665. Data is available for 4 years (2020–2023), covering 23 distinct procedure/service records.

Practice Information

  • Specialty Internal Medicine
  • Other Specialties Internal Medicine, Hematology & Oncology
  • Location Milwaukee, WI
  • Active Since 01/26/2010
  • Last Updated 10/01/2020
  • Taxonomy Code 207R00000X
  • Entity Type Individual
  • NPI Number 1710218011

Products in Payments

  • XPOVIO (Drug) $85,718
  • DARZALEX (Biological) $61,545
  • Revlimid (Drug) $44,793
  • ELREXFIO (Drug) $37,205
  • CARVYKTI (Biological) $20,993
  • VENCLEXTA (Drug) $18,225
  • CARVYKTI (Drug) $15,194
  • TECVAYLI (Biological) $14,136
  • NINLARO (Drug) $12,866
  • BLENREP (Biological) $11,550
  • SARCLISA (Biological) $9,909
  • DARZALEX (Drug) $4,981
  • Kyprolis (Biological) $4,556
  • Tecartus (Drug) $3,820
  • ABECMA (Biological) $3,515
  • TALVEY (Biological) $2,160
  • Pomalyst (Drug) $1,597
  • Cellsearch (Device) $688.78
  • clonoSEQ (Device) $624.77
  • Imbruvica (Drug) $122.26

Data Sources

Provider data from NPPES. Payment data from CMS Open Payments. Medicare data from CMS Medicare Provider Utilization. All data is public and updated periodically.

Internal Medicine Doctors in Milwaukee